换一批
换一批Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.
第一作者：
Alexander S,Parker
第一单位：
Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA. Electronic address: parker.alexander@mayo.edu.
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗原, 肿瘤(Antigens, Neoplasm);活组织检查(Biopsy);癌, 肾细胞(Carcinoma, Renal Cell);DNA拓扑异构酶类, Ⅱ型(DNA Topoisomerases, Type II);DNA结合蛋白质类(DNA-Binding Proteins);女(雌)性(Female);佛罗里达(Florida);人类(Humans);免疫组织化学(Immunohistochemistry);Kaplan-Meiers评估(Kaplan-Meier Estimate);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);中年人(Middle Aged);明尼苏达(Minnesota);多元分析(Multivariate Analysis);坏死(Necrosis);肿瘤分期(Neoplasm Staging);肾切除术(Nephrectomy);观察者偏差(Observer Variation);试验预期值(Predictive Value of Tests);比例危险度模型(Proportional Hazards Models);登记(Registries);结果可重复性(Reproducibility of Results);危险性评估(Risk Assessment);危险因素(Risk Factors);时间因素(Time Factors);治疗结果(Treatment Outcome);肿瘤负荷(Tumor Burden);增量调节(Up-Regulation);青年人(Young Adult)
DOI
10.1016/j.eururo.2013.12.017
PMID
24388441
发布时间
2021-10-21
- 浏览122
European urology
929-35页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
